Opko Health, Inc. (OPK): who owns it and who trades it
As of Nov 16, 2026, OPK insiders reported 2 open-market sales worth $24.6K and 33 purchases worth $3M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was John A Paganelli (Director), with $24.6K. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Opko Health
From the latest filingsOverall: more buying than selling. Insiders and famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns OPK
222 funds and institutions reported OPK shares worth $309M at the end of Q2 2026, about 27% of the company. The largest holder is Rubric Capital Management LP with 6.3%.
Funds and institutions (13F) 27%Everyone else 73%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Rubric Capital Management LP | 47.79M | 6.33% | $71.7M | No change |
| BlackRock, Inc. | 36.98M | 4.90% | $55.5M | +2% |
| Vanguard Capital Management LLC | 14.97M | 1.98% | $22.5M | +3% |
| Vanguard Portfolio Management LLC | 14.93M | 1.98% | $22.4M | +1% |
| Geode Capital Management, LLC | 11.58M | 1.53% | $17.4M | +2% |
| State Street Corp | 10.31M | 1.37% | $15.5M | +9% |
| Goldman Sachs Group Inc | 7.04M | 0.93% | $10.6M | -8% |
| UBS Group AG | 5.01M | 0.66% | $7.5M | -18% |
| Whitefort Capital Management, LP | 4.51M | 0.60% | $6.8M | +6% |
| Northern Trust Corp | 3.76M | 0.50% | $5.6M | +4% |
| Charles Schwab Investment Management Inc | 3.60M | 0.48% | $5.4M | +1% |
| Sixth Street Partners Management Company, L.P. | 3.60M | 0.48% | $5.4M | – |
| Highbridge Capital Management LLC | 3.59M | 0.48% | $5.4M | – |
| Vanguard Fiduciary Trust Co | 2.71M | 0.36% | $4.1M | -1% |
| AWM Investment Company, Inc. | 2.11M | 0.28% | $3.2M | +0% |
| Morgan Stanley | 1.98M | 0.26% | $3M | +65% |
| California State Teachers Retirement System | 1.44M | 0.19% | $961K | +248% |
| Citadel Advisors LLC | 1.42M | 0.19% | $2.1M | -32% |
| Washington Growth Strategies LLC | 1.36M | 0.18% | $2M | No change |
| Bank of New York Mellon Corp | 1.33M | 0.18% | $2M | +4% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, OPK insiders reported $3M of open-market purchases and $24.6K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | John A Paganelli | Director | Sale | 4,426 | $1.78 | $7.9K | Form 4 |
| Nov 5, 2026 | John A Paganelli | Director | Sale | 9,175 | $1.82 | $16.7K | Form 4 |
| Mar 20, 2026 | John A Paganelli | Director | Purchase | 10,000 | $1.14 | $11.4K | Form 4 |
| Nov 21, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 89,375 | $1.33 | $119K | Form 4 |
| Nov 21, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 191,490 | $1.33 | $255K | Form 4 |
| Nov 21, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 3,894 | $1.32 | $5.1K | Form 4 |
| Nov 21, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 102,371 | $1.30 | $133K | Form 4 |
| Nov 21, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 192,870 | $1.34 | $258K | Form 4 |
| Nov 20, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 161,818 | $1.34 | $217K | Form 4 |
| Nov 20, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 24,579 | $1.34 | $32.9K | Form 4 |
| Nov 20, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 1,757 | $1.35 | $2.4K | Form 4 |
| Nov 20, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 211,948 | $1.33 | $282K | Form 4 |
| Nov 20, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 119,129 | $1.32 | $157K | Form 4 |
| Nov 20, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 47,105 | $1.33 | $62.6K | Form 4 |
| Nov 20, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 13,664 | $1.35 | $18.4K | Form 4 |
| Nov 19, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 21,236 | $1.30 | $27.6K | Form 4 |
| Nov 19, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 198,904 | $1.32 | $263K | Form 4 |
| Nov 19, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 36,325 | $1.28 | $46.5K | Form 4 |
| Nov 19, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 58,160 | $1.29 | $75K | Form 4 |
| Nov 19, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 300 | $1.29 | $387 | Form 4 |
| Nov 19, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 155,496 | $1.32 | $205K | Form 4 |
| Nov 19, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 30,082 | $1.30 | $39.1K | Form 4 |
| Nov 19, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 12,993 | $1.31 | $17K | Form 4 |
| Nov 19, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 66,504 | $1.31 | $87.1K | Form 4 |
| Nov 18, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 212,608 | $1.28 | $272K | Form 4 |
| Nov 18, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 1,772 | $1.27 | $2.3K | Form 4 |
| Nov 18, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 15,000 | $1.27 | $19.1K | Form 4 |
| Nov 18, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 66,635 | $1.26 | $84K | Form 4 |
| Nov 18, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 49,590 | $1.25 | $62K | Form 4 |
| Nov 18, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 410 | $1.25 | $512 | Form 4 |
| Nov 18, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 33,572 | $1.29 | $43.3K | Form 4 |
| Nov 18, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 1 | $1.29 | $1 | Form 4 |
| Nov 18, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 83,556 | $1.29 | $108K | Form 4 |
| Nov 18, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 69,728 | $1.28 | $89.3K | Form 4 |
| Nov 18, 2025 | Frost Gamma Investments Trust +1 | 10% owner | Purchase | 428 | $1.28 | $548 | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Frost Gamma Investments Trust | 10% owner | $3M | – | Nov 21, 2025 |
| John A Paganelli | Director | $11.4K | $24.6K | Nov 5, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
OPK short interest
Low short interest. 4.4% of OPK shares are sold short: about 1 share in 23. Over the last 12 reports the number of shares short went up 1%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 32.85M OPK shares were sold short, 4.4% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 3.56M shares, buying them all back would take about 9.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 32.85M | 4.42% | -3% | 3.56M | 9.2 |
| Oct 15, 2026 | 34.01M | 4.56% | -4% | 6.47M | 5.3 |
| Sep 30, 2026 | 35.56M | 4.76% | -1% | 2.38M | 14.9 |
| Sep 15, 2026 | 35.99M | 4.82% | +4% | 3.41M | 10.6 |
| Aug 31, 2026 | 34.56M | 4.63% | +3% | 2.51M | 13.8 |
| Aug 14, 2026 | 33.65M | 4.51% | +2% | 2.72M | 12.4 |
| Jul 31, 2026 | 32.88M | 4.41% | -2% | 6.10M | 5.4 |
| Jul 15, 2026 | 33.64M | 4.46% | +3% | 2.60M | 13.0 |
| Jun 30, 2026 | 32.59M | 4.32% | -1% | 3.65M | 8.9 |
| Jun 15, 2026 | 32.79M | 4.34% | -1% | 2.77M | 11.8 |
| May 29, 2026 | 33.04M | 4.38% | +1% | 3.03M | 10.9 |
| May 15, 2026 | 32.66M | 4.32% | -3% | 1.97M | 16.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Opko Health company events
Opko Health filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 4, 2026.
- Nov 4, 2026ResultsReleased financial results. Filing
- Oct 15, 2026AgreementOPKO Health, Inc., a Delaware corporation, its wholly owned subsidiary, BioReference Health, LLC, and Laboratory Corporation of America Holdings, a Delaware corporation, entered into an Asset Purchase Agreement. Filing
- Oct 2, 2026AnnouncementOPKO Health, Inc. determined that its 3.75% Convertible Senior Notes due 2029, of which approximately $121 million is outstanding, are convertible by holders of such Notes through December 31, 2026. Filing
- Aug 14, 2026AgreementOPKO Health, Inc. entered into an amendment to the initial Note Purchase Agreement dated July 17, 2024 (the “Original Agreement”; and as amended by the Amendment, the “Amended Agreement”) with certain purchasers party thereto from time to time, its wholly-owned subsidiaries OPKO Biologics Ltd. and… Filing
- Jul 27, 2026ResultsReleased financial results. Filing
- Jun 18, 2026VoteReported shareholder vote results. Filing
- Apr 28, 2026ResultsReleased financial results. Filing
- Mar 19, 2026LeadershipThe Board of Directors of OPKO Health, Inc., appointed Subbarao V. Uppaluri, Ph.D. as a new director with immediate effect to serve until the Company’s 2026 Annual Meeting of Stockholders and until his successor shall be duly elected or appointed or his earlier death or resignation. Filing
- Feb 26, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Opko Health financials
Famous investors that hold OPK
5 of the 50 well-known investors we track reported holding OPK in their latest 13F filing. The largest position is Ken Griffin's, worth $4.5M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 2.77M | $4.5M | 0.0% | +95% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 1.01M | $1.6M | 0.0% | New |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 244,821 | $394K | 0.0% | No change |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 242,987 | $391K | 0.0% | +67% |
| Israel Englander · Millennium Management | Q3 2026 | 137,297 | $221K | 0.0% | +90% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Opko Health, Inc. (OPK) stock
Who owns the most OPK stock?
The largest reported owner of Opko Health, Inc. (OPK) is Rubric Capital Management LP, with 6.3% of the company. In total, 222 funds and institutions reported holding OPK at the end of Q2 2026, together about 27% of the shares. See the largest owners.
Are OPK insiders buying or selling?
In the last 12 months, OPK insiders reported 33 open-market purchases worth $3M and 2 sales worth $24.6K. The latest trade was on Nov 5, 2026. See every trade.
What is the short interest in OPK?
As of Oct 30, 2026, 32.85M OPK shares were sold short, 4.4% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 3.56M shares, buying them all back would take about 9.2 trading days (days to cover). See the history.
Which famous investors hold OPK?
5 of the 50 well-known investors we track reported OPK in their latest 13F filing, including Ken Griffin, Jim Simons, Paul Tudor Jones. The largest position is worth $4.5M. See all holders.
Executive pay
Opko Health's chief executive was paid a total of $1.9M for the year ended Dec 31, 2025, down 14% from $2.2M the year before. In the last 12 months, Opko Health's executives and directors bought $11.4K of stock on the open market and sold $24.6K.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.